Clinical trial of Adathoda rasayanam for the management of bronchial asthma in children

Clinical evaluation of Adathoda rasayanam for the management of soolikanam(childhood asthma)in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019294

Enrollment

Registered

2019-05-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: Adathoda rasayanam: Adathoda rasayanam, dosage 170 mg-3-4 years,500mg-5-7 years,oral route for 45 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Cough,Wheezing,Tightness of chest,Shortness of breath,Abdominal bloating,Loss of appetite

Exclusion criteria

Exclusion criteria: Hemoptysis,Active primary complex,Congenital heart disease,Pneumonia,Status Asthmaticus,Any other serious illness

Design outcomes

Primary

Measure	Time frame
Efficacy of the trial drug is measured by peak expiratory flow meterTimepoint: 28 days	—

Secondary

Measure	Time frame
Reduction in the recurrence of the disease and improvement in the quality of life of children,Improvement in clinical symptomsTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr K Suresh

National institute of siddha

mmssiddha@gmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026